F-star Therapeutics to Present at The Society for Immunotherapy of Cancer (SITC) 2021 Conference Dr. Michelle Morrow to present on F-star’s Proprietary Bispecific Platform including FS118, our LAG-3/PD-L1 Bispecific Poster Presentation of Preclinical Data Demonstrates Potential for F-star’s...

F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...